Humana Inc. (HUM): Price and Financial Metrics
Humana Inc. (HUM)
Today's Latest Price: $403.91 USD
Updated Aug 5 8:03pm
Add HUM to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 9 in Medical - Health Insurance
See all "A" rated Strong Buy stocks
HUM Stock Summary
- HUM has a market capitalization of $51,716,370,071 -- more than approximately 96.09% of US stocks.
- The capital turnover (annual revenue relative to shareholder's equity) for HUM is 5.48 -- better than 91.93% of US stocks.
- HUM's went public 34.62 years ago, making it older than 92.88% of listed US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to Humana Inc are ODP, RUSHA, SHW, FOSL, and LECO.
- HUM's SEC filings can be seen here. And to visit Humana Inc's official web site, go to www.humana.com.
HUM Stock Price Chart Technical Analysis Charts
HUM Price/Volume Stats
| Current price | $403.91 | 52-week high | $412.70 |
| Prev. close | $391.18 | 52-week low | $208.25 |
| Day low | $394.51 | Volume | 905,234 |
| Day high | $404.75 | Avg. volume | 1,212,040 |
| 50-day MA | $390.29 | Dividend yield | 0.64% |
| 200-day MA | $354.59 | Market Cap | 53.40B |
Humana Inc. (HUM) Company Bio
Humana operates as a health and well-being company. The company operates through three segments: Retail, Group, and Healthcare Services. The company was founded in 1964 and is based in Louisville, Kentucky.
HUM Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $403.91 | $1102.74 | 182% |
We started the process of determining a valid price forecast for Humana Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Humana Inc ranked in the 69th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 183.17% on a DCF basis. The most interesting components of our discounted cash flow analysis for Humana Inc ended up being:
- HUM's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 31.1% of tickers in our DCF set.
- The weighted average cost of capital for the company is 7. This value is greater than merely 24.89% stocks in the Healthcare sector that generate free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 176% |
| 1% | 179% |
| 2% | 182% |
| 3% | 185% |
| 4% | 187% |
| 5% | 190% |
PCRX, DVA, NVO, TVTY, and EGRX can be thought of as valuation peers to HUM, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...